HomeXRTX • NASDAQ
add
XORTX Therapeutics Inc
Previous close
$1.43
Day range
$1.32 - $1.40
Year range
$1.09 - $7.00
Market cap
5.46M CAD
Avg Volume
94.64K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 935.37K | -37.27% |
Net income | 170.07K | 110.05% |
Net profit margin | — | — |
Earnings per share | -0.69 | 18.70% |
EBITDA | -887.90K | 39.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.08M | -50.06% |
Total assets | 4.80M | -38.48% |
Total liabilities | 2.09M | 419.43% |
Total equity | 2.70M | — |
Shares outstanding | 2.90M | — |
Price to book | 1.54 | — |
Return on assets | -43.10% | — |
Return on capital | -88.35% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 170.07K | 110.05% |
Cash from operations | -736.54K | 57.41% |
Cash from investing | -9.08K | 4.76% |
Cash from financing | -8.86K | 12.66% |
Net change in cash | -756.97K | 56.60% |
Free cash flow | 143.25K | 114.80% |
About
Founded
2011
Headquarters
Website
Employees
3